0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

Sodium tanshinone IIA sulfonate ameliorates neointima by protecting endothelial progenitor cells in diabetic mice

BMC Cardiovascular Disorders 2023 5 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 35 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Yan-Yan Heng, Hui-Juan Shang, X C Zhang, Wei Wei

Summary

Researchers found that a compound called sodium tanshinone IIA sulfonate (STS) protected blood vessel repair cells (endothelial progenitor cells) in diabetic mice, reducing harmful artery wall thickening by blocking an inflammation pathway. This suggests STS may help prevent cardiovascular complications linked to diabetes-related vascular damage.

STS inhibits the aggravated neointima hyperplasia by protecting the proliferation and differentiation functions of EPC and inhibiting EPC senescence in diabetic mice. The mechanism is related to the preservation of CAT activity by inhibiting the RAGE-TXNIP-NLRP3 inflammasome pathway.

Sign in to start a discussion.

More Papers Like This

Article Tier 2

STS Protects Diabetic Glomerular Vascular Endothelial Barrier by Ameliorating EPC Dysfunction: Targeting RAGE-TXNIP-NLRP3 Inflammasome Pathway

This study investigated how a compound called STS (Sodium Tanshinone IIA Sulfonate) protects kidney blood vessels in diabetic kidney disease by targeting an inflammatory pathway. STS helped repair endothelial progenitor cells that are damaged by diabetes, reducing kidney injury. This paper is focused on a therapeutic mechanism in diabetes and is not directly related to microplastics.

Article Tier 2

SGLT2 inhibition ameliorates nano plastics-induced premature endothelial senescence and dysfunction

Researchers found that nanoplastics cause premature aging and dysfunction in blood vessel lining cells, and that an SGLT2 inhibitor drug could help counteract these effects. The nanoplastics triggered oxidative stress and inflammation in endothelial cells, which are linked to cardiovascular problems. The study suggests a potential therapeutic approach to address some of the vascular damage associated with nanoplastic exposure.

Article Tier 2

2,7-Phloroglucinol-6,6′-bieckol from Ecklonia cava ameliorates nanoplastics-induced premature endothelial senescence and dysfunction

Researchers found that a compound called PHB derived from the marine algae Ecklonia cava protects coronary artery cells from nanoplastic-induced premature aging and vascular dysfunction by reducing oxidative stress, suppressing senescence-promoting proteins, and restoring nitric oxide production essential for blood vessel relaxation.

Article Tier 2

Abstract 10442: Protective Effect of Inhibition of Sglt2 on Nanoplastics-Induced Premature Endothelial Senescence and Dysfunction

Researchers investigated whether SGLT2 inhibition (gliflozins) protects against nanoplastic-induced premature endothelial senescence and dysfunction, using porcine coronary artery rings and cultured endothelial cells to examine a redox-sensitive signaling pathway through which nanoplastics impair cardiovascular endothelial health.

Article Tier 2

Galangin attenuates oxidative stress-mediated apoptosis in high glucose-induced renal tubular epithelial cells through modulating renin–angiotensin system and PI3K/AKT/mTOR pathway

Researchers found that a plant compound called galangin protected kidney cells from damage caused by high blood sugar by reducing oxidative stress and activating protective signaling pathways. While focused on diabetes treatment, this research is not directly related to microplastic contamination.

Share this paper